Resmed Inc. buy UBS Group AG
Start price
21.07.26
/
50%
€172.05
Target price
21.07.27
-
Performance (%)
10.58%
Price
18.08.26
€190.25
Summary
This prediction is currently active. The prediction currently has a performance of 10.58%. This prediction currently runs until 21.07.27. The prediction end date can be changed by UBS_Group_AG at any time. UBS_Group_AG has 50% into this predictionPerformance without dividends (%)
| Name | 1w |
|---|---|
| Resmed Inc. | -2.336% |
| iShares Core DAX® | -0.874% |
| iShares Nasdaq 100 | -0.381% |
| iShares Nikkei 225® | -1.676% |
| iShares S&P 500 | -0.655% |
Comments by UBS_Group_AG for this prediction
In the thread Resmed Inc. diskutieren
ResMed (RMD) had its "buy" rating reaffirmed by UBS Group AG.
Ratings data for RMD provided by MarketBeat